Mingqiu Chen1 article listing Mingqiu Chen in Nature Communications, indexed by Paperzzz from Crossref and OSF.Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO) Nature Communications